Introduction to the Endocrine System

Principles of Endocrinology and Hormone Mechanisms

• Definition and Scope of Endocrinology

  • Endocrinology is the scientific study of hormones, their receptors, and the physiological reflex pathways that regulate internal homeostasis.

  • Hormones manage long-term, ongoing physiological functions of the body, including:

    • Metabolism

    • Regulation of the internal environment (temperature, fluid, and electrolyte balance)

    • Reproductive processes

    • Growth and physical development

  • The human body secretes and circulates approximately $50$ distinct hormones.

• Three Fundamental Mechanisms of Hormone Action

  • Controlling rates of enzymatic reactions.

  • Transporting ions or molecules across cell membranes.

  • Controlling gene expression and protein synthesis within target cells.

• Classical Methodology for Endocrine Identification

  • Remove the suspected endocrine gland to produce a state of hormone deficiency.

  • Replace the hormone by administering gland extracts or synthetic molecules to reverse deficiency symptoms.

  • Create a state of hormone excess by over-administering the substance to observe hypersecretion signs.

• Chemical Signal Properties of Hormones

  • Hormones are chemical signals secreted by a cell or group of specialized cells into the extracellular fluid (ECF) or directly into the blood.

  • They are transported by blood plasma to distant target tissues where they bind to specific receptors.

  • Growth factors function at short distances via autocrine (acting on the same cell) or paracrine (acting on adjacent cells) signaling.

  • Pheromones are specialized ectohormones secreted into the external environment. For example, copulins are natural pheromones produced by females prior to ovulation to stimulate sexual attraction and activity in males.

  • Hormones exert cellular effects at extremely low physiological concentrations, typically in the range of $10^{-9}\,M$ to $10^{-12}\,M$.

• Cellular Mechanism of Action and Termination

  • Hormone actions depend on binding to target cell surface or intracellular receptors to initiate biochemical signal transduction cascades.

  • Hormone action must be terminated once the physiological requirement is met; signal duration is quantified by half-life, which represents the time required for the plasma hormone concentration to decrease by half.

  • Exocrine secretions differ from endocrine secretions as exocrine glands secrete chemicals through ducts onto epithelial surfaces or into external lumen space (e.g., tears from lacrimal glands, perspiration from sudoriferous glands, saliva from salivary glands, and hydrochloric acid ($HCl$) secreted into the stomach lumen by parietal cells).

Chemical Classes and Synthesis of Hormones

• Endocrine Gland and Target Organ Summary

  • Pineal Gland: Secretes Melatonin (amino acid derivative) -> Targets brain and peripheral tissues -> Regulates circadian rhythms, immune function, and antioxidant activity.

  • Hypothalamus: Secretes Trophic Hormones (peptides/amino acid derivatives) -> Targets anterior pituitary -> Regulates anterior pituitary hormone release.

  • Posterior Pituitary: Stores and releases Oxytocin (peptide) -> Targets breast and uterus (milk ejection, labor, delivery) and Vasopressin / Antidiuretic Hormone (ADH) (peptide) -> Targets kidney distal tubules (water reabsorption).

  • Anterior Pituitary: Secretes Prolactin (PRL) [breast milk production], Growth Hormone (GH / Somatotropin) [liver and soft tissue growth/metabolism], Corticotropin (ACTH) [adrenal cortex cortisol release], Thyrotropin (TSH) [thyroid hormone synthesis], Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) [gonadal sex hormone and germ cell production]. All anterior pituitary hormones are peptides.

  • Thyroid Gland: Secretes Triiodothyronine ($T_3$) and Thyroxine ($T_4$) (amino acid derivatives) -> Targets many tissues (metabolism, growth, development); secretes Calcitonin (peptide) -> Targets bone (minimal calcium-lowering effect in humans).

  • Parathyroid Gland: Secretes Parathyroid Hormone (PTH) (peptide) -> Targets bone and kidney -> Regulates plasma $Ca^{2+}$ and phosphate levels.

  • Thymus Gland: Secretes Thymosin and Thymopoietin (peptides) -> Targets lymphocytes -> Drives T-lymphocyte development.

  • Heart: Secretes Atrial Natriuretic Peptide (ANP) (peptide) -> Targets kidneys -> Increases $Na^+$ excretion.

  • Liver: Secretes Angiotensinogen (peptide) -> Targets adrenal cortex and blood vessels (aldosterone secretion, vasoconstriction) and Insulin-like Growth Factors (IGFs) (peptide) -> Targets tissues for growth.

  • Stomach and Small Intestine: Secretes Gastrin, Cholecystokinin (CCK), Secretin (peptides) -> Targets GI tract and pancreas -> Assists digestion and nutrient absorption.

  • Pancreas: Secretes Insulin, Glucagon, Somatostatin, Pancreatic Polypeptide (peptides) -> Targets liver, muscle, adipose -> Regulates glucose and nutrient metabolism.

  • Adrenal Cortex: Secretes Aldosterone (steroid) -> Targets kidney ($Na^+$ and $K^+$ homeostasis); Cortisol (steroid) -> Targets tissues (stress response, glucose regulation); Androgens (steroid) -> Targets tissues (female sex drive).

  • Adrenal Medulla: Secretes Epinephrine and Norepinephrine (amine/catecholamine) -> Targets tissues -> Flight-or-fight sympathetic response.

  • Kidney: Secretes Erythropoietin (peptide) -> Targets bone marrow (red blood cell production); 1,25-Dihydroxy-vitamin $D_3$ (calciferol) (steroid) -> Targets intestine (increases $Ca^{2+}$ absorption).

  • Skin: Secretes Vitamin $D_3$ (steroid precursor) -> Intermediate form converted to calciferol.

  • Testes: Secretes Androgens (steroid) -> Targets tissues (sperm production, secondary sex characteristics); Inhibin (peptide) -> Targets anterior pituitary (inhibits FSH).

  • Ovaries: Secretes Estrogen and Progesterone (steroids) -> Targets tissues (egg production, secondary sex traits); Inhibin (peptide) -> Targets anterior pituitary (inhibits FSH); Relaxin (peptide) -> Targets uterine muscle (muscle relaxation during pregnancy).

  • Adipose Tissue: Secretes Leptin, Adiponectin, Resistin (peptides) -> Targets hypothalamus -> Regulates food intake, metabolism, and reproduction.

  • Placenta: Secretes Estrogen (steroid) -> Fetal/maternal development; Chorionic Somatomammotropin (peptide) -> Metabolism; Chorionic Gonadotropin (peptide) -> Maintains corpus luteum.

• Comparison of Peptide, Steroid, and Amine Hormones

  • Peptide Hormones:

    • Synthesis and Storage: Made in advance as inactive precursors; stored in membrane-bound secretory vesicles.

    • Release: Released via exocytosis upon regulatory signal.

    • Transport: Highly water-soluble; dissolved in blood plasma.

    • Half-life: Short (minutes).

    • Receptor Location: Cell membrane outer surface.

    • Cellular Mechanism: Activation of second messenger systems (e.g., cAMP via G protein-coupled receptors or tyrosine kinase pathways); modifies existing proteins and induces new protein synthesis.

    • Examples: Insulin, Parathyroid Hormone (PTH).

  • Steroid Hormones:

    • Synthesis and Storage: Lipophilic; synthesized on demand from cholesterol precursors in the adrenal cortex or gonads; cannot be stored in vesicles.

    • Release: Simple diffusion across cell membrane as soon as synthesized.

    • Transport: Bound to plasma protein carriers (e.g., albumin, corticosteroid-binding globulin); only unbound free steroid diffuses into cells.

    • Half-life: Long (e.g., Cortisol half-life = $60\text{ to }90\,\text{minutes}$).

    • Receptor Location: Cytoplasm or nucleus (genomic action); some cell membrane receptors (rapid non-genomic actions).

    • Cellular Mechanism: Receptor-hormone complex binds DNA response elements to activate or repress gene transcription and translation, inducing new protein synthesis.

    • Examples: Estrogen, Androgens, Cortisol, Aldosterone.

  • Amine Hormones (Tyrosine Derivatives - Catecholamines vs. Thyroid Hormones):

    • Catecholamines (Epinephrine, Norepinephrine, Dopamine): Made in advance and stored in secretory vesicles; released by exocytosis; dissolved in plasma; short half-life; bind cell membrane receptors; activate second messenger systems to modify existing proteins.

    • Thyroid Hormones (Thyroxine / $T_4$, Triiodothyronine / $T_3$): Synthesized in advance from two tyrosine molecules and iodine ($I$) atoms; precursors stored in thyroid follicular colloid; released via transport protein carriers; bound to carrier proteins in blood; long half-life; bind nuclear receptors to activate gene transcription and translation, inducing new protein synthesis.

• Peptide Hormone Processing Pathways

  • mRNA on ribosomes directs amino acid assembly into a preprohormone containing a signal sequence.

  • The signal sequence guides the protein chain into the endoplasmic reticulum (ER) lumen.

  • Enzymes in the ER chop off the signal sequence, generating an inactive prohormone.

  • The prohormone travels via transport vesicles from the ER through the Golgi complex.

  • Secretory vesicles contain enzymes that cleavage-chop the prohormone into one or more active peptide hormones plus additional peptide fragments.

  • PreproTRH ($242\text{ amino acids}$) is processed into $6$ active copies of the $3\text{-amino acid}$ hormone TRH.

  • Pro-opiomelanocortin (POMC) is cleaved into ACTH, $\gamma\text{-lipotropin}$, and $\beta\text{-endorphin}$.

  • Proinsulin folds back on itself using disulfide ($S-S$) bonds; proteolytic cleavage yields active insulin and C-peptide (connecting peptide).

• Clinical Diagnostic Utility of C-Peptide

  • A C-peptide blood test quantifies endogenous insulin production by the pancreas.

  • Normal fasting plasma C-peptide levels range from 0.5\text{ to }2.0\,ng/mL$.\n * *Type 1 Diabetes Mellitus*: Low or undetectable C-peptide levels due to autoimmune destruction of pancreatic \beta cells.\n * *Type 2 Diabetes Mellitus*: Normal or elevated C-peptide levels due to compensatory hypersecretion of insulin to overcome target cell insulin resistance.\n\n\n\n* **Steroid Hormone Synthesis from Cholesterol**\n * Cholesterol is the parent compound for all steroid hormones.\n * Conversion of cholesterol into progesterone, corticosterone, and aldosterone occurs in the adrenal cortex.\n * Cortisol synthesis requires the enzyme 21\text{-hydroxylase}.\n * In the ovaries, the enzyme aromatase converts testosterone into estradiol, and androstenedione into estrone.\n * In male target tissues, testosterone is converted by 5\alpha\text{-reductase} into dihydrotestosterone (DHT).\n\n\n\n# Endocrine Reflex Pathways and Pituitary Gland Integration\n\n* **Simple Endocrine Reflexes**\n * In simple endocrine pathways, the endocrine cell itself acts as both sensor and integrating center.\n * *Parathyroid Hormone (PTH) Reflex Pathway*:\n * Stimulus: Low plasma Ca^{2+} concentration.\n * Sensor/Integrating Center: Parathyroid cells equipped with Ca^{2+} cell surface receptors.\n * Efferent Signal: Secretion of PTH into the blood.\n * Target Tissues: Bone and kidney.\n * Tissue Response: Increased bone resorption of Ca^{2+}$, increased renal$Ca^{2+}$reabsorption, and production of calcitriol ($1,25\text{-dihydroxy-vitamin }D_3$) leading to enhanced intestinal$Ca^{2+} absorption.\n * Systemic Response: Plasma Ca^{2+} concentration increases, restoring normal levels and shutting off PTH secretion via negative feedback.\n * *Complex Insulin Secretion Pathways*:\n * Direct pathway: High blood glucose stimulates pancreatic \beta cells to release insulin directly.\n * Neural pathway: Meal ingestion stretches the digestive tract -> activates stretch receptors -> sensory neurons -> Central Nervous System (CNS) -> efferent parasympathetic neurons -> pancreas -> insulin release.\n * Incretin pathway: Nutrient glucose in the gut lumen -> intestinal endocrine cells secrete Glucagon-like Peptide-1 (GLP-1) -> pancreas -> insulin release -> target tissues increase glucose uptake and utilization -> blood glucose drops, terminating the reflex.\n\n\n\n* **Anatomy and Division of the Pituitary Gland**\n * The pituitary gland sits in a protective bony pocket of the sphenoid bone (sella turcica) and connects to the hypothalamus by a thin stalk called the infundibulum.\n * It is composed of two embryologically distinct tissues:\n * **Posterior Pituitary (Neurohypophysis)**: An extension of neural tissue from the brain. Synthesizes no hormones directly; stores and secretes two neurohormones synthesized in hypothalamic cell bodies: Vasopressin (ADH) and Oxytocin.\n * **Anterior Pituitary (Adenohypophysis)**: A true endocrine gland of epithelial origin that secretes six classic peptide hormones.\n * **Intermediate Lobe**: A thin vestigial cellular layer in humans that secretes Melanocyte-Stimulating Hormone (MSH).\n\n\n\n* **Hypothalamic-Hypophyseal Portal System**\n * A portal system consists of two capillary beds connected in series by portal veins.\n * Hypothalamic neurons release trophic releasing (-RH) or inhibiting (-IH) neurohormones into the primary capillary bed in the infundibulum.\n * Portal veins transport these hormones directly to the secondary capillary bed inside the anterior pituitary.\n * This arrangement ensures that minute quantities of hypothalamic trophic hormones reach their anterior pituitary target cells directly without being diluted in the systemic circulation.\n\n# Hypothalamic-Pituitary Control Axes and Feedback Loops\n\n\n\n* **Hypothalamic-Anterior Pituitary Axis Relationships**\n * Dopamine (Prolactin-Inhibiting Hormone, PIH) -> Inhibits Prolactin (PRL) secretion -> Targets female breast for lactation control.\n * Thyrotropin-Releasing Hormone (TRH) -> Stimulates Thyrotropin / Thyroid-Stimulating Hormone (TSH) -> Targets thyroid gland to release Thyroid Hormones (T_3$,$T_4).\n * Corticotropin-Releasing Hormone (CRH) -> Stimulates Adrenocorticotropin / Adrenocorticotropic Hormone (ACTH) -> Targets adrenal cortex to release Cortisol.\n * Growth Hormone-Releasing Hormone (GHRH, dominant) -> Stimulates Growth Hormone (GH / Somatotropin); Somatostatin (SS / Growth Hormone-Inhibiting Hormone, GHIH) -> Inhibits GH -> Targets liver to release Insulin-like Growth Factors (IGFs) and soft tissues for growth/metabolism.\n * Gonadotropin-Releasing Hormone (GnRH) -> Stimulates Gonadotropins: Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) -> Targets endocrine cells of the gonads to release Androgens (males) or Estrogens and Progesterone (females), directing germ cell maturation.\n\n* **Feedback Architecture in Complex Endocrine Axes**\n * *Long-Loop Negative Feedback*: The final hormone produced by the peripheral endocrine gland (H_3$, e.g., Cortisol) exerts negative feedback control by suppressing tropic hormone secretion from both the anterior pituitary ($IC_2$) and hypothalamus ($IC_1). This is the dominant feedback mechanism.\n * *Short-Loop Negative Feedback*: The anterior pituitary hormone (H_2$, e.g., Prolactin, GH, ACTH) feeds back to suppress hypothalamic trophic neurohormone release ($H_1).\n * *Ultra-Short-Loop Negative Feedback*: Occurs locally within the hypothalamus or pituitary, where a secreted hormone acts via autocrine or paracrine pathways to inhibit its own secretion by the same cell type.\n\n* **Hormone Interactions**\n * **Synergism**: Occurs when two or more hormones interact at target cells such that their combined physiological effect is greater than additive.\n * *Glucagon, Epinephrine, and Cortisol Interaction*: Plasma glucose baseline = 80\,mg/dL$. Glucagon alone elevates blood glucose slightly ($\sim 100\,mg/dL$); Epinephrine alone elevates it moderately ($\sim 115\,mg/dL$); Cortisol alone produces marginal changes. Glucagon + Epinephrine raises blood glucose to$150\,mg/dL$. Glucagon + Epinephrine + Cortisol synergistically elevates blood glucose to$250\,mg/dL.\n * **Permissiveness**: A physiological interaction where one hormone cannot exert its full biological effect unless a second permissive hormone is present, even if the permissive hormone itself has no direct action (e.g., Thyroid hormone is permissive for GnRH-mediated reproductive system maturation).\n * **Antagonism**: Occurs when one hormone opposes the action of another. May be competitive antagonism (competing for the same receptor, such as Tamoxifen blocking estrogen receptors) or functional antagonism (acting through distinct pathways with opposite physiological outcomes, such as glucagon increasing blood glucose while insulin lowers it).\n\n\n\n# Endocrine Pathologies, Diabetes Mellitus, and Diagnostic Algorithms\n\n* **General Endocrine Pathologies**\n * **Hypersecretion**: Excess hormone secretion exaggerating systemic responses. Caused by functional tumors (adenomas) or exogenous iatrogenic medical therapies.\n * Exogenous hormone administration (e.g., prednisone/cortisol therapy) triggers negative feedback on the hypothalamus and anterior pituitary, suppressing endogenous CRH and ACTH. Chronic lack of trophic ACTH causes target gland atrophy of the adrenal cortex. Exogenous steroid treatment must be tapered off gradually to allow the atrophied gland time to restore normal secretory capacity.\n * **Hyposecretion**: Hormone deficiency diminishing tissue responses. Caused by biosynthetic enzyme defects, nutritional deficiencies, or tissue atrophy/destruction.\n * *Adrenal Tuberculosis*: Tuberculous infection destroying greater than 90\% of the adrenal cortex, resulting in adrenal insufficiency and Addisonian crisis (fatigue, abdominal pain, hypotension, life-threatening metabolic failure). Histology shows tuberculous granulomas, caseous necrosis, fibrosis, and calcification.\n * **Abnormal Target Tissue Responsiveness**:\n * *Down-Regulation*: Decreased target cell receptor density in response to chronically elevated plasma hormone concentrations to reduce tissue sensitivity (e.g., Hyperinsulinemia inducing insulin receptor down-regulation).\n * *Receptor/Signal Transduction Abnormalities*: Genetic mutations producing nonfunctional or missing receptors (e.g., Type 2 Diabetes Mellitus).\n\n* **Thyroid Disorders**\n * **Hypothyroidism**:\n * *Hashimoto's Disease*: Autoimmune disease where autoantibodies attack thyroid tissue, destroying synthetic enzymes and blocking T_3$/$T_4 production. Symptoms include weight gain, severe fatigue, cold intolerance, and irritability; treated with Levothyroxine.\n * *Myxedema*: Severe adult hypothyroid state characterized by low basal metabolic rate (BMR), mental sluggishness, cold sensitivity, weight gain, and non-pitting mucopolysaccharide skin edema.\n * *Endemic Goiter*: Iodine deficiency prevents T_3/T_4 production. Lack of negative feedback causes excessive TSH secretion. The thyroid gland enlarges as it accumulates unusable non-iodinated colloid. Historically endemic in the American Midwest due to iodine-deficient soil; largely eradicated by iodized salt.\n * *Cretinism (Congenital Hypothyroidism)*: Infant hypothyroidism causing severe physical dwarfism and irreversible mental retardation ("cretinism" derived from Greek "Kretan" meaning little monster). Reversible if identified through newborn blood screening and treated early with thyroid hormone replacement.\n * **Hyperthyroidism**:\n * *Graves' Disease*: Autoimmune disorder where abnormal autoantibodies (Thyroid-Stimulating Immunoglobulins, TSI) act as agonist ligands for TSH receptors, overstimulating thyroid hormone synthesis.\n * Chief Clinical Symptoms: Exophthalmos / Proptosis (bulging eyes caused by fluid-attracting glycosaminoglycans deposited behind the orbits), toxic goiter, tachycardia, extreme excitability, muscle weakness, weight loss.\n * Treatment: Surgical thyroidectomy or administration of radioactive iodine (^{131}I) to ablate thyroid cells, followed by lifelong synthetic thyroid hormone replacement.\n\n* **Growth Hormone (GH) Pathologies**\n * **Hypersecretion of GH**:\n * *Gigantism*: Occurs in children prior to epiphyseal plate fusion; causes extreme long-bone elongation (heights exceeding 8\,\text{feet}).\n * *Case Example*: Robert Wadlow reached a height of 8\,\text{feet } 11\,\text{inches}$, weighed$440\,\text{lbs}$, wore a size$25$ring and size$37AA$shoes, and died at age$22 due to foot ulcer complications.\n * *Acromegaly*: Occurs in adults after epiphyseal plate closure; causes bone thickening in the face, hands, and feet, prominent frontal bossing, nasal base widening, lip thickening, and mandible protrusion ("acro" derived from Greek *akros* meaning topmost or tip).\n * **Hyposecretion of GH**:\n * *Pituitary Dwarfism*: Occurs in children; results in short stature (2\text{ to }4\,\text{feet}) with normal limb-to-trunk body proportions.\n\n* **Diabetes Mellitus (DM)**\n * "Diabetes" means siphon/running through; "Mellitus" means sweetness (glucose running through urine without being utilized). Distinct from Diabetes Insipidus (caused by ADH deficiency).\n * **Type 1 Diabetes Mellitus**: Formerly juvenile-onset or Insulin-Dependent DM (IDDM). Affects \sim 1\text{ million}$Americans. Sudden autoimmune onset usually before age$15$. Immune system antibodies selectively destroy pancreatic$\beta cells, eliminating insulin production. Requires daily exogenous insulin administration. Associated with low/absent C-peptide.\n * **Type 2 Diabetes Mellitus**: Formerly adult-onset or Non-Insulin-Dependent DM (NIDDM). Accounts for 90\%$of all cases ($\sim 12\text{ million}$Americans). Typically seen in overweight adults over age$40, now increasingly diagnosed in children. Strong hereditary link. Caused by insulin resistance, receptor down-regulation, or defective GLUT transporter translocation. Managed by dietary restriction, exercise, oral hypoglycemics, and insulin. Associated with normal or elevated C-peptide.\n * *Pathophysiology of Insulin Deficit*:\n * Absence of insulin action -> Severe Hyperglycemia -> Plasma becomes hypertonic -> Draws water out of tissue cells -> Cellular dehydration.\n * Hyperglycemia exceeds renal glucose threshold -> Glycosuria (glucose in urine) -> Glucose creates osmotic gradient -> Osmotic diuresis -> Polyuria (excessive urination) -> Dehydration -> Polydipsia (excessive thirst).\n * Intracellular glucose starvation -> Polyphagia (excessive hunger).\n * Unchecked lipolysis -> Free fatty acids metabolized by liver into acidic ketone bodies -> Ketoacidosis (low blood pH, Kussmaul respiration, acetone breath) + Ketonuria -> Urinary cation loss (Na^+$,$K^+$,$H^+) -> Hypokalemia, cardiac dysrhythmias, CNS depression, coma.\n * Long-term complications: Microvascular and macrovascular disease, peripheral neuropathy, impaired wound healing, foot ulcers, gangrene, lower-extremity amputations, diabetic retinopathy (blindness), and stroke.\n\n\n\n* **Diagnostic Algorithms for Endocrine Pathologies**\n * *Primary Pathology*: Defect resides in the final target endocrine gland in the axis.\n * *Primary Hypercortisolism*: Adrenal cortex tumor produces excess Cortisol -> High Cortisol feedback suppresses pituitary and hypothalamus -> Plasma Cortisol = High, ACTH = Low, CRH = Low.\n * *Secondary Pathology*: Defect resides in the anterior pituitary gland.\n * *Secondary Hypercortisolism*: Anterior pituitary tumor produces excess ACTH -> High ACTH drives cortisol secretion; high cortisol suppresses hypothalamus -> Plasma Cortisol = High, ACTH = High, CRH = Low.\n * *Tertiary Pathology*: Defect resides in the hypothalamus.\n * *Tertiary Hypercortisolism*: Hypothalamic tumor produces excess CRH -> High CRH drives ACTH, which drives Cortisol -> Plasma Cortisol = High, ACTH = High, CRH = High.\n\n* **Pineal Gland Physiology**\n * Melatonin ("darkness hormone") is synthesized from tryptophan in the pineal gland.\n * Melatonin secretion follows a circadian rhythm: baseline day levels (\sim 10\,pg/mL$plasma) rise sharply at night, peaking around midnight to$2\,\text{AM}$($\sim 50\,pg/mL plasma), before dropping at dawn.\n * Blue light emitted from electronic screens suppresses pineal melatonin secretion, disrupting sleep initiation.\n\n# Structural and Functional Classification of Neurons\n\n\n\n* **Overview of Nervous System Organization**\n * Neurons are the basic functional units of the nervous system, transmitting electrical and chemical signals. End-to-end, all human body neurons would stretch approximately 599\,\text{miles}.\n * Nerves are bundles of peripheral axons encased in connective tissue (sensory, motor, or mixed nerves).\n\n* **Structural Neuron Categories**\n * *Pseudounipolar Neurons*: Possess a single process called an axon that bifurcates; during embryonic development, the dendrite fused with the axon. Characteristic of somatic sensory neurons.\n * *Bipolar Neurons*: Possess two relatively equal fibers extending off opposite sides of the central cell body. Found in specialized sensory systems (smell, vision).\n * *Anaxonic Neurons*: CNS interneurons that lack an identifiable axon.\n * *Multipolar Neurons*: Possess numerous branching dendrites and a single long axon. Typical CNS interneurons are highly branched; typical multipolar efferent motor neurons have 5\text{ to }7$main dendrites that branch$4\text{ to }6 times, ending in enlarged axon terminals or varicosities.\n\n* **Functional Neuron Categories**\n * *Sensory (Afferent) Neurons*: Conduct information regarding somatic senses or visceral input from peripheral receptors to the CNS.\n * *Efferent Neurons*: Carry somatic motor impulses to skeletal muscles or autonomic signals to smooth muscle, cardiac muscle, exocrine/endocrine glands.\n * *Interneurons*: Located entirely within the CNS; integrate incoming sensory signals and coordinate efferent output.\n\n* **Anatomy of a Functional Neuron**\n * *Cell Body (Soma)*: Metabolic control center containing the nucleus, Golgi apparatus, and Nissl bodies (dense rough ER).\n * *Dendrites*: Receptive branches receiving incoming signals; surface area expanded by dendritic spines.\n * *Axon Hillock (Trigger Zone)*: The specialized axon region where incoming graded potentials integrate; contains a high density of voltage-gated Na^+ channels to initiate action potentials.\n * *Axon Terminal*: Secretory region that releases chemical neurotransmitters into the synaptic cleft.\n\n# Axonal Transport and Synaptic Architecture\n\n\n\n* **Axonal Transport Mechanisms**\n * Because axons lack ribosomes for protein synthesis, cellular components must be actively transported from the cell body down the axon length.\n * **Fast Axonal Transport**:\n * Moves membrane-bound organelles, synaptic vesicles, and mitochondria along microtubule tracks using motor proteins.\n * Velocity: Up to 400\,mm/day$($15.75\,\text{inches/day}).\n * *Anterograde Transport*: Moves new vesicles, enzymes, and mitochondria from soma toward the axon terminal.\n * *Retrograde Transport*: Moves old membrane components and endosomes from the axon terminal back to the soma for lysosomal degradation.\n * **Slow Axonal Transport**:\n * Transports non-perishable cytoskeletal proteins and microfilaments via axoplasmic (cytoplasmic) flow.\n * Velocity: 0.2\text{ to }8.0\,mm/day$.

• Synapse Formation, Plasticity, and Repair

  • A synapse is the specialized junction where a presynaptic axon terminal meets a postsynaptic target cell across a $20\text{ to }30\,nm$ synaptic cleft.

  • Developing axons navigate toward targets guided by specialized tips called growth cones under the influence of neurotrophic factors.

  • Synapses are plastic structures that undergo remodeling based on environmental inputs and electrical activity throughout life.

  • Peripheral Nerve Injury and Repair:

    • Axon transection -> Axoplasm leaks and seals severed ends; proximal segment swells.

    • The distal axon segment, deprived of soma-derived proteins, undergoes Wallerian degeneration; myelin sheaths unravel.

    • Macrophages and phagocytes clear tissue debris.

    • Schwann cells secrete neurotrophic factors to maintain soma viability and form a regeneration tube guiding proximal axon regrowth.

  • CNS Injury: Regeneration is rare because CNS astrocytes and oligodendrocytes express surface factors that actively inhibit axonal elongation.

Glial Cell Physiology and Myelination Pathologies

• Glial Cells of the Peripheral Nervous System (PNS)

  • Schwann Cells: Form insulating myelin sheaths around peripheral axons. A single Schwann cell wraps around a single $1\text{ to }1.5\,mm$ segment of one axon in concentric concentric membrane layers.

  • Satellite Cells (Amphicytes): Non-myelinating glial cells forming supportive capsules around neuronal cell bodies inside peripheral ganglia, maintaining microenvironmental homeostasis.

• Glial Cells of the Central Nervous System (CNS)

  • Oligodendrocytes: Form insulating myelin sheaths around CNS axons; one oligodendrocyte extends multiple processes to myelinate segments of up to $50$ distinct axons.

  • Astrocytes: Star-shaped glia whose perivascular foot processes envelope cerebral capillaries to form the tight junctions of the Blood-Brain Barrier (BBB). Functions: take up excess $K^+$, water, and neurotransmitters (glutamate); secrete neurotrophic factors; supply energy substrates (lactate) for ATP production.

  • Microglia: Specialized CNS macrophages (modified immune cells) acting as scavengers that engulf cellular debris, apoptotic cells, and invading pathogens.

  • Ependymal Cells: Epithelial cells lining brain ventricles and the central canal of the spinal cord; create a selectively permeable barrier separating fluid compartments, synthesize Cerebrospinal Fluid (CSF), and serve as a source of neural stem cells.

• Myelination and Saltatory Conduction

  • Myelin consists of multiple concentric layers of phospholipid cell membranes that electrically insulate the axon, preventing current leak out into the ECF.

  • Nodes of Ranvier: Unmyelinated gaps ($1\text{ to }1.5\,mm$ spacing) along myelinated axons where the axolemma is exposed to the ECF; voltage-gated $Na^+$ and $K^+$ channels are concentrated here.

  • Saltatory Conduction: Depolarization at one node creates a local current that spreads passively down the insulated internode segment to quickly bring the adjacent node to threshold. The action potential appears to jump rapidly from node to node at velocities up to $150\,m/s$ ("saltatory" derived from Latin saltar meaning to jump, discovered by French scientist Louis Antoine Ranvier).

• Demyelinating Diseases

  • Multiple Sclerosis (MS):

    • Autoimmune demyelinating disease affecting young adults in the CNS.

    • Pathophysiology: Antibodies destroy CNS myelin sheaths. Current leaks out of previously insulated internodal membrane regions. Because internodal axolemma lacks voltage-gated $Na^+$ channels, local current dissipates below threshold before reaching the next node, causing conduction slowing or complete action potential failure.

    • Clinical Features: Progressive muscular weakness, loss of motor coordination, visual and speech disturbances; characterized by relapsing-remitting episodes.

    • Compensatory Adaptation: Neurons synthesize new voltage-gated $Na^+$ channels in the soma and transport them anterogradely to insert into bare demyelinated axolemma, restoring slow continuous conduction.

  • Guillain-Barré Syndrome (GBS):

    • Autoimmune demyelinating disorder of the Peripheral Nervous System (PNS).

    • Frequently preceded by Campylobacter jejuni gastroenteritis ($\sim 1\text{ in }1000$ cases).

    • Symptoms: Sudden onset of weakness, distal extremity tingling, ascending motor paralysis that may cause respiratory failure.

Electrophysiology: Resting Potential and Action Potential Dynamics

• Ion Concentration Gradients and Equilibrium Potentials

  • The resting membrane potential ($V_m$) of a typical neuron is $-70\,mV$.

  • $V_m$ is determined primarily by the membrane permeability to $K^+$ through leak channels and the concentration gradients of key ions:

    • Potassium ($K^+$): Extracellular = $5\,mM$ ($3.5\text{ to }5.0\,mM$ physiological range); Intracellular = $150\,mM$; Equilibrium Potential ($E_{K^+}$) at $37\,^\circ C$ = $-90\,mV$.

    • Sodium ($Na^+$): Extracellular = $145\,mM$ ($135\text{ to }145\,mM$ range); Intracellular = $15\,mM$; Equilibrium Potential ($E_{Na^+}$) at $37\,^\circ C$ = $+60\,mV$.

    • Chloride ($Cl^-$): Extracellular = $108\,mM$ ($100\text{ to }108\,mM$ range); Intracellular = $10\,mM$ ($5\text{ to }15\,mM$ range); Equilibrium Potential ($E_{Cl^-}$) at $37\,^\circ C$ = $-63\,mV$.

    • Calcium ($Ca^{2+}$): Extracellular = $1\,mM$; Intracellular = $0.0001\,mM$.

  • The $Na^+/K^+$ ATPase electrogenic pump maintains these concentration gradients by pumping $3\,Na^+$ out of the cell for every $2\,K^+$ pumped in per ATP hydrolyzed.

• Gated Ion Channels

  • Voltage-Gated Channels: Open/close in response to changes in membrane potential (e.g., fast voltage-gated $Na^+$ channels and slow voltage-gated $K^+$ channels).

  • Mechanically Gated Channels: Open/close in response to physical membrane deformation, pressure, stretch, or vibration (e.g., auditory hair cell receptors, skin mechanoreceptors).

  • Chemically Gated (Ligand-Gated) Channels: Open/close in response to binding of a specific ligand (e.g., acetylcholine at nicotinic cholinergic receptors).

  • Electromagnetic (Light)-Gated Channels: Open/close in response to photon absorption (e.g., retinal photoreceptors).

• Graded Potentials versus Action Potentials

  • Graded Potentials:

    • Variable amplitude proportional to stimulus strength.

    • Travel via local current flow down dendrites and soma.

    • Lose signal strength over distance due to current leak across open membrane channels and cytoplasmic resistance.

    • Subthreshold Graded Potential: Arrives at the trigger zone below threshold ($-55\,mV$); fails to fire an action potential.

    • Suprathreshold Graded Potential: Arrives at the trigger zone at or above threshold ($-55\,mV$); triggers an action potential.

  • Action Potentials:

    • All-or-none electrical signals of constant, non-decremental amplitude ($+30\,mV$ peak).

    • Propagate along the axon over long distances.

• Sequential Phases of the Action Potential Waveform

  1. Resting Membrane Potential: $V_m = -70\,mV$; high relative resting permeability to $K^+$ via leak channels.

  2. Depolarizing Stimulus: A suprathreshold graded potential reaches the axon hillock trigger zone.

  3. Threshold Reached: $V_m$ depolarizes to $-55\,mV$; activation gates of fast voltage-gated $Na^+$ channels open rapidly.

  4. Rising Phase: Rapid $Na^+$ influx down its electrochemical gradient depolarizes the membrane toward $E_{Na^+}$, reversing polarity to a peak of $+30\,mV$.

  5. Peak Polarity / Inactivation: At $+30\,mV$, voltage-gated $Na^+$ channel inactivation gates close, halting $Na^+$ entry ($P_{Na}$ drops). Slower voltage-gated $K^+$ channels open fully.

  6. Falling Phase: Rapid $K^+$ efflux down its electrochemical gradient repolarizes the cell membrane toward resting levels.

  7. After-Hyperpolarization (Undershoot): Voltage-gated $K^+$ channels remain open briefly after reaching $-70\,mV$, driving $V_m$ toward $E_{K^+}$ ($-90\,mV$).

  8. Resetting: Voltage-gated $K^+$ channels close; normal leak channel permeability returns $V_m$ to $-70\,mV$.

  • Ion Gradients Unchanged: A single action potential moves an insignificant fraction of total cellular ions; ion concentration gradients remain functionally unchanged.

• Voltage-Gated $Na^+$ Channel Gating and Refractory Periods

  • Voltage-gated $Na^+$ channels possess two separate gates: a fast activation gate and a slow inactivation gate.

  • Positive Feedback Loop: Depolarization opens activation gates -> $Na^+$ influx -> further depolarization -> opens additional $Na^+$ activation gates. The loop is broken when slow inactivation gates close at $+30\,mV$.

  • Absolute Refractory Period (ARP):

    • Time interval ($1\text{ to }2\,msec$) during which a second action potential cannot be initiated regardless of stimulus strength.

    • Coincides with open or inactivated voltage-gated $Na^+$ channels. Inactivation gates must reset to resting positions before re-opening.

    • Prevents backward conduction of action potentials toward the soma.

  • Relative Refractory Period (RRP):

    • Follows the ARP. A second action potential can be triggered, but requires a stronger-than-normal (suprathreshold) stimulus.

    • Coincides with ongoing $K^+$ efflux while $V_m$ is hyperpolarized. The resulting action potential has a lower amplitude peak.

Pharmacological Agents and Chemical Modulation of Excitation

• Plasma Potassium ($K^+$) Pathologies

  • Normokalemia: Plasma $[K^+] = 3.5\text{ to }5.0\,mM$. Normal resting potential ($-70\,mV$).

  • Hyperkalemia: Elevated plasma $[K^+]$. Reduces the outward concentration gradient for $K^+$, retaining positive charge inside the cell and depolarizing the resting membrane potential closer to threshold ($-55\,mV$). Subthreshold stimuli can now trigger action potentials, causing hyperexcitability and cardiac dysrhythmias.

  • Hypokalemia: Decreased plasma $[K^+]$. Increases the outward concentration gradient for $K^+$, driving $K^+$ efflux and hyperpolarizing the resting membrane potential away from threshold. Neurons become less excitable, requiring larger suprathreshold stimuli to fire action potentials.

• Pharmacological and Toxicological Modulators

  • Diethyl Ether / Chloroform: General volatile anesthetics that open $K^+$ channels, driving $K^+$ efflux. The hyperpolarized membrane prevents action potential initiation, suppressing brain activity.

  • Lidocaine / Novocain / Xylocaine: Local anesthetics that bind and block the inner pore of voltage-gated $Na^+$ channels, preventing $Na^+$ influx, action potential generation, and pain impulse conduction.

  • Tetrodotoxin (TTX): Potent neurotoxin isolated from pufferfish (Fugu) gonads/liver. Selectively blocks voltage-gated $Na^+$ channels, halting action potential propagation and causing muscle paralysis and death via respiratory arrest.

  • Curare / $\alpha\text{-Bungarotoxin}$: Snake/plant venoms containing active ingredients like D-tubocurarine that competitively block nicotinic acetylcholine receptors at the neuromuscular junction, causing skeletal muscle paralysis.

  • Ouabain: Specific inhibitor of the $Na^+/K^+$ ATPase pump. Has no immediate effect on a single, newly generated action potential because individual action potentials rely on passive ion flux through voltage-gated channels, not active pumps.

Neurotransmitter Systems, Synaptic Transmission, and Long-Term Potentiation

• Major Neurotransmitter Classes

  • Acetylcholine (ACh): Synthesized in axon terminals from choline (derived from membrane phospholipids) and acetyl CoA (from the citric acid cycle) by choline acetyltransferase.

    • Nicotinic Receptors: Ionotropic monovalent cation channels ($Na^+$ and $K^+$) located on skeletal muscle neuromuscular junctions, autonomic ganglia, and CNS.

    • Muscarinic Receptors: Metabotropic G protein-coupled receptors (GPCRs) located on parasympathetic autonomic target tissues and CNS.

  • Amines:

    • Serotonin (5-HT): Derived from tryptophan; active in the CNS.

    • Histamine: Derived from histidine.

    • Catecholamines: Derived from tyrosine. Include Dopamine, Norepinephrine, and Epinephrine. Adrenergic receptors ($\alpha_1, \alpha_2, \beta_1, \beta_2, \beta_3$) are GPCRs.

  • Amino Acids:

    • Glutamate: Primary excitatory neurotransmitter in the CNS; acts on AMPA and NMDA ionotropic receptors.

    • Aspartate: Excitatory neurotransmitter in the brain.

    • Gamma-Aminobutyric Acid (GABA): Primary inhibitory neurotransmitter in the brain; hyperpolarizes target cells by opening $Cl^-$ channels.

    • Glycine and D-Serine: Inhibitory neurotransmitters in the spinal cord; enhance the excitatory effects of glutamate.

  • Peptides: Substance P and opioid peptides (enkephalins, endorphins) modulate pain pathways; Cholecystokinin (CCK), Vasopressin, and ANP act as central neurohormones.

  • Purines: Adenosine, AMP, and ATP bind purinergic GPCRs.

  • Gases: Nitric Oxide ($NO$), Carbon Monoxide ($CO$), and Hydrogen Sulfide ($H_2S$) diffuse freely across cell membranes.

  • Lipids: Endogenous eicosanoids and endocannabinoids bind cannabinoid receptors.

• Mechanisms of Vesicular Neurotransmitter Release

  • Classical Pathway:

    1. An action potential depolarizes the presynaptic axon terminal.

    2. Depolarization opens voltage-gated $Ca^{2+}$ channels; $Ca^{2+}$ enters the cell down its concentration gradient.

    3. $Ca^{2+}$ binds regulatory synaptotagmin proteins, triggering exocytosis of synaptic vesicles anchored to docking proteins.

    4. Neurotransmitter diffuses across the synaptic cleft and binds to postsynaptic receptors.

    5. Receptor activation initiates a postsynaptic response.

  • Kiss-and-Run Pathway: Synaptic vesicles briefly dock and fuse with the presynaptic membrane to form a transient fusion pore, release neurotransmitter, and pinch back off into the cytoplasm.

• Termination of Neurotransmitter Signal

  • Reuptake into presynaptic axon terminals or surrounding glial cells via active transport.

  • Enzymatic inactivation within the cleft (e.g., Acetylcholinesterase, AChE, rapidly hydrolyzes ACh into acetate and choline; choline is cotransported back into the terminal with $Na^+$ to synthesize new ACh).

  • Passive diffusion away from the synaptic cleft into blood vessels.

• Stimulus Strength Coding

  • Individual action potentials display constant amplitude.

  • Stimulus intensity and duration are coded by the frequency of action potential firing (higher frequency = greater total neurotransmitter release per unit time).

• Postsynaptic Responses and Integration

  • Fast Synaptic Potentials: Mediated by ionotropic receptor-channels. Opening $Na^+$ channels causes net $Na^+$ influx -> Excitatory Postsynaptic Potential (EPSP = depolarizing). Opening $K^+$ or $Cl^-$ channels causes $K^+$ efflux or $Cl^-$ influx -> Inhibitory Postsynaptic Potential (IPSP = hyperpolarizing).

  • Slow Synaptic Potentials: Mediated by metabotropic G protein-coupled receptors. Activates second messenger pathways that modify existing channel proteins, alter open states, or regulate nuclear gene transcription.

  • Temporal Summation: Summation occurring when two or more subthreshold graded potentials generated by the same presynaptic terminal arrive at the trigger zone close together in time, combining to reach threshold.

  • Spatial Summation: Summation occurring when subthreshold graded potentials originating from different presynaptic neurons arrive at the trigger zone simultaneously, combining to reach threshold.

• Presynaptic Modulation

  • Global Presynaptic Inhibition: An inhibitory input targets the postsynaptic cell body or hillock, preventing an action potential from initiating at the trigger zone. All downstream target collateral cells receive no signal.

  • Selective Presynaptic Inhibition: An inhibitory modulatory neuron synapses selectively onto a single collateral axon terminal of a presynaptic neuron. It blocks neurotransmitter release at that single synapse while allowing all other axon collaterals to transmit signals to their target cells normally.

• Long-Term Potentiation (LTP)

  • LTP is a process of activity-dependent synaptic plasticity in the CNS underlying learning and memory formation.

  • Glutamate-Mediated LTP Sequence:

    1. Presynaptic neuron releases Glutamate into the synaptic cleft.

    2. Glutamate binds to both AMPA and NMDA ionotropic receptors on the postsynaptic membrane.

    3. Net $Na^+$ influx through AMPA receptor-channels depolarizes the postsynaptic membrane.

    4. Depolarization electrostatically repels and ejects the magnesium ion ($Mg^{2+}$) blocking the pore of the NMDA channel.

    5. $Ca^{2+}$ enters the postsynaptic cell through the unblocked NMDA channel.

    6. Intracellular $Ca^{2+}$ activates second messenger kinase cascades.

    7. Postsynaptic cell sensitivity increases by inserting additional AMPA receptors into the postsynaptic membrane and releasing a retrograde paracrine messenger (e.g., Nitric Oxide) that enhances future presynaptic glutamate release.